Neimeth International Pharmaceuticals Plc

NGSE:NEIMETH Stock Report

Market Cap: ₦50.2b

Neimeth International Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

J. Valentine Okelu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.4yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO

J. Valentine Okelu

2.4yrs
Tenure

Mr. Pharm. J. Valentine C. Okelu is MD, CEO & Director of Neimeth International Pharmaceuticals Plc from September 2023. Mr. Okelu has Bachelor's from University of Nigeria Nsukka. Mr. Okelu has Master's i...

Board Members

NamePositionTenureCompensationOwnership
J. Valentine Okelu
MD, CEO & Director2.4yrsno datano data
Roseline Oputa
Executive Director of Sales & Marketing8.3yrsno datano data
Mazi Sam Ohuabunwa
Non Executive Directorno datano datano data
Christopher Oshiafi
Chairman1.7yrsno datano data
Ikechukwu Onyechi
Non Executive Director14.2yrsno datano data
Maurice Iwu
Non Executive Director14.2yrsno datano data
Atinuke Uwajeh
Non-Executive Director2.5yrsno datano data
Olusegun Akanji
Non-Executive Director2.5yrsno datano data
Henrietta Orjiako
Non-Executive Director1.7yrsno datano data
Eric Okoruwa
Non-Executive Director1.7yrsno datano data
Adeyemi Odusanya
Independent Non-Executive Director1.3yrsno datano data
Patricia Aderibigbe
Independent Non-Executive Director1.3yrsno datano data
2.4yrs
Average Tenure

Experienced Board: NEIMETH's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/18 21:59
End of Day Share Price 2026/02/18 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Neimeth International Pharmaceuticals Plc is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullMeristem Securities Limited